Skip to main content
. 2021 Aug 26;94(1):178–185. doi: 10.1002/jmv.27290

Table 2.

SARS‐CoV‐2® Test antibodies response according to days after RNA confirmation and clinical severity

Days after RNA (DR) for SARS‐CoV‐2
All 1–7 8–13 14–31 ≥32
No. samples 218 86 22 59 51
No. positive for IgG (%) 178 (82) 78 (91) 21 (96) 51 (86) 28 (55)
No. positive for IgA (%) 105 (48) 65 (76) 12 (55) 27 (46) 1 (2)
All Asymptomatic Mild Moderate Severe
No. samples 218 42 56 25 95
No. positive for IgG (%) 178 (82) 25 (60) 34 (61) 24 (96) 95 (100)
No. positive for IgA (%) 105 (48) 2 (5) 8 (9) 11 (44) 84 (88)

Note: Percentage of samples by days after RNA according to test result (one spot or more ≥70 Virachip® units for IgG and two spots or more for IgA).

Abbreviation: SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.